Health
‘Potent’ neutralizing antibody studies and what they could mean for a coronavirus treatment | TheHill – The Hill
Although it would need to be tested in clinical trials, monoclonal antibodies can bind to the coronavirus and may prevent severe illness.
Were finding out more about the coronavirus and COVID-19 every week, and lately there have been reports that fewer people than expected may develop antibodies to the virus after infection. Experts are still hopeful that synthetic antibodies may one day be used as a therapeutic for the coronavirus.
A study recently published in Nature identifies a mix of 19 different antibodies that target SARS-CoV-2, the coronavirus that causes COVID-19. Several studies like this have been published since the s…
-
Noosa News24 hours agoMoreton Bay oyster farm survives cyclone with help of wave wall innovation
-
General23 hours agoPort’s lease a ‘mistake’ as major parties flag takeover
-
Business22 hours agoThese ASX 200 shares could rise 50% to 60%
-
General21 hours agoAustralia’s Myanmar community mourns earthquake losses